Best Interactive Sessions For 2018!

Here are 3 interactive sessions I know you don’t want to miss…

PANEL DISCUSSION

Outlining the considerations to be made for a successful global oncology trial

• Outlining key cultural differences
• Using feasibility tests to understand patient populations and availability
• Patient recruitment and screening processes
• Best practices for vendor selection for that region
• Assess the regulatory landscape and ethical requirements to identify your competitive advantage

Panellists: Tarja Jalava, Head Global Clinical Project Management Oncology II, Oncology Strategic Business Unit, Bayer

Jean-Pierre Latere, COO, Celyad SA

Amer Alghabban, VP Quality Assurance, Compliance & Training, Karyopharm Therapeutics

WORKSHOP

Establishing strategies for vendor management and oversight to strengthen collaboration and achieve goals throughout your trial

• Highlighting the specific requirements you need from your vendor during protocol design
• Setting up an effective vendor oversight plan
• Assessing vendor performance after your study to incorporate lessons learned into future projects
• What are the latest technologies for active monitoring allowing for timely problem solving?

Martin Orlovius, Head of Clinical Operations, 4SC AG

INTERACTIVE DEBATE

‘Is patient centricity something for now or the future?’

• Everyone is talking about patient centricity but is anyone actually acting on it?
• Discussing how we define the correct language to use with the patients in mind
• Delving into the tools available for improving patient involvement
• Debating at what stage and what level of input should we include patients and
• Patient Advocacy Groups to develop better patient-centric policies

Julie Charlton, Group Director of Scientific Project Management, AstraZeneca

Cesare Spadoni, Chairman, aPODD Foundation